A mini-review of anti-hepatitis B virus activity of medicinal plants

• Published in: Biotechnology, biotechnological equipment Vol. 31; no. 1; pp. 9 - 15
• Main Authors: Siddiqui, Manzer H., Alamri, Saud A., Al-Whaibi, Mohamed H., Hussain, Zahid, Ali, Hayssam M., El-Zaidy, Mohamed E.
• Format: Journal Article
• Language: English
• Published: Sofia Taylor & Francis 02-01-2017; Taylor & Francis Ltd; Taylor & Francis Group
• Subjects: Anti-hepatitis B virus; Antiviral activity; Antiviral agents; Dengue fever; Health services; Hepatitis; Hepatitis A; Hepatitis B; Herbal medicine; HIV; Human immunodeficiency virus; Infections; Infectious diseases; Influenza; Liver diseases; Medical treatment; medicinal plant; Medicinal plants; Natural products; Peptides; Pharmaceutical industry; Pharmaceuticals; Plant diseases; Side effects; Vector-borne diseases; Viruses
• ISSN: 1310-2818; 1314-3530
• DOI: 10.1080/13102818.2016.1240593

Medicinal plants are of undoubted value, as they have been used for centuries to treat various diseases and health disorders in almost every part of the world. In several studies, the use of medicinal plants was found effective in treatment of infectious and non-infectious diseases. The World Health Organization has been working for many years to identify all surviving medicinal plants on the earth. An important step has also been taken by the Natural Health Product Regulation of Canada for promotion and usages of natural products. At present, the rapidly growing population of the world is facing many challenges from various infectious diseases that are associated with hepatitis A, B and C virus, human immunodeficiency virus, influenza virus, dengue virus and new emerging viruses. Hepatitis B virus causes a severe and frequently transmittable disease of the liver. Millions of people worldwide suffer from hepatitis B virus (HBV) infection. The drugs available on the market for the treatment of hepatitis B are not sufficient and also cause side effects in patients suffering from HBV infection. The pharmaceutical companies are searching for suitable alternative and natural inhibitors of HBV. Therefore, it is important to explore and use plants as a source of new medicines to treat this infectious disease, because single plants contain a priceless pool of active ingredients which could help in the production of pharmaceutical-grade peptides or proteins. However, the knowledge of the antiviral activity of medicinal plants is still limited.